![Daniel Baker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Baker
Directeur/Membre du Conseil chez
SHATTUCK LABS, INC.
Fortune : - $ au 31/05/2026
Profil
Daniel G.
Baker is currently an Independent Director at Shattuck Labs, Inc. and Artiva Biotherapeutics, Inc., both starting in 2025.
Dr. Baker is also the Chief Development Officer at Cue Biopharma, Inc. since 2024.
Formerly, Dr. Baker was Chief Executive Officer & Director at Kira Biotech Pty Ltd. Dr. Baker was an Independent Non-Executive Director at Lakefront Biotherapeutics from 2022 to 2024.
From 2000 to 2019, Dr. Baker was Vice President-Immunology R&D at Johnson & Johnson.
Dr. Baker earned a doctorate from the University of Pennsylvania and completed undergraduate studies at Gettysburg College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Daniel Baker
| Sociétés | Poste | Début |
|---|---|---|
| CUE BIOPHARMA, INC. | Corporate Officer/Principal | 25/11/2024 |
| ARTIVA BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 28/01/2025 |
| SHATTUCK LABS, INC. | Directeur/Membre du Conseil | 25/08/2025 |
Anciens postes connus de Daniel Baker
| Sociétés | Poste | Fin |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Directeur/Membre du Conseil | 06/10/2024 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/01/2019 |
Kira Biotech Pty Ltd.
 Kira Biotech Pty Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops novel immunomodulatory compounds for the treatment of immune system disorders | Directeur Général | - |
Formation de Daniel Baker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
87
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gettysburg College
 Gettysburg College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Shattuck Labs, Inc.
 Shattuck Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for inflammatory and immune-mediated diseases | Health Technology |
Kira Biotech Pty Ltd.
Kira Biotech Pty Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops novel immunomodulatory compounds for the treatment of immune system disorders | Health Technology |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers | Health Technology |
